Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Travis Coy is using his Big Pharma bona fides to prioritize business development at the diversified and growing company.

Eli Lilly CEO David Ricks just made a show of ... s feature covering stock transactions by corporate executives and board members—so-called insiders—as well as large shareholders, politicians ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

The 200-acre Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers, including engineers, ...

Thus, Medicare coverage could trigger a domino effect, leading to broader insurance coverage across the board and substantially boosting Eli Lilly's sales potential in the obesity market.

Copyright 2025 The Associated Press. All Rights Reserved. A sign for Eli Lilly & Co. appears outside their corporate headquarters in Indianapolis on April 26, 2017 ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.